Explore by Category


Clinical Trial: Can Yoga Help Alleviate Peripheral Neuropathy After Chemo?

CLINICAL TRIALS - January 12, 2022

A randomized Phase III clinical trial is being run at Memorial Sloan Kettering Cancer Center to see if yoga helps alleviate chemo-induced peripheral neuropathy.... Read More

Clinical Trial: A New Myeloma Therapy Tasquinimod Targeting MDSCs

CLINICAL TRIALS - November 19, 2021

A new oral treatment that targets the tumor microenvironment and changes the immune system called tasquinimod is now in early multiple myeloma clinica... Read More

ADVERTISEMENT
Debunking Clinical Trial Myths with Dr. Craig Cole

CLINICAL TRIALS - November 18, 2021

Clinical trials are one of the key factors to accelerating myeloma research and getting us closer to the cure we all desire. Thanks to clinical trials, eff... Read More

Clinical Trial: A Personalized Vaccine in Smoldering Myeloma at MD Anderson Cancer Center

CLINICAL TRIALS - October 28, 2021

Many approaches are attempting to prevent smoldering myeloma from progressing to active myeloma. One such approach is a personalized vaccine being developed at ... Read More

ADVERTISEMENT
Clinical Trials: Venetoclax for Multiple Myeloma 11;14 Translocation Patients

CLINICAL TRIALS - March 24, 2021

Multiple myeloma patients who have the 11;14 translocation may want to consider using venetoclax (Venclexta) as a treatment option. While venetoclax isn't y... Read More

Clinical Trial: New Phase II Trial Opens for Pfizer's Multiple Myeloma Bispecific Antibody Elrantamab

CLINICAL TRIALS - February 18, 2021

A new Phase II clinical trial of Pfizer's multiple myeloma bispecific antibody called elrantamab is opening at six trial sites (CA, IN, KY, SC), The study, ... Read More

ADVERTISEMENT
FDA Removes Clinical Trial Hold on Cellectis Off-the-Shelf CAR T for Multiple Myeloma

CLINICAL TRIALS - November 18, 2020

The clinical trial hold for UCART, an allogeneic (off-the-shelf) CAR T product by Cellectis has been removed by the FDA and the MELANI-01 trial is now able to m... Read More

Belantamab Mafodotin Teams with SpringWorks Drug to Increase BCMA Expression in Early Myeloma Trial

CLINICAL TRIALS - August 04, 2020

An early Phase I clinical trial is combining GlaxoSmithKline's belentabmab mafodotin with SpringWorks Therapeutics' nirogacestat with people with re... Read More

ADVERTISEMENT
Myeloma Clinical Trials Explained: CLR-131

CLINICAL TRIALS - June 08, 2020

Written by Melissa McMahon, SparkCures At SparkCures, our mission is to help people with multiple myeloma find, understand and connect with their clinical tr... Read More

Feelings, Fatigue and Fitness: Help Roswell Park Myeloma Researcher Complete His Fitness/Health Myeloma Study

CLINICAL TRIALS - June 01, 2020

How do you feel right now? And how fit are you? Myeloma specialist Jens Hillengass, MD, Chief of the Roswell Park Cancer Institute multiple myeloma program is r... Read More

XPOVIO (selinexor) Study Shows Impact When Used in Earlier Lines of Multiple Myeloma Therapy with Velcade and Dex

CLINICAL TRIALS - March 11, 2020

Using XPOVIO (selinexor) and Velcade weekly with low-dose dexamethasone showed a 47% increase in progression free survival compared to Velcade (twice weekly) ... Read More

Clinical Trial: Smoldering Myeloma Personalized Vaccine at MD Anderson

CLINICAL TRIALS - February 06, 2020

Could a vaccine prevent smoldering myeloma from progressing to active myeloma? An early Phase I clinical trial at MD Anderson Cancer Center is developing a pers... Read More

Clinical Trial: Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma

CLINICAL TRIALS - June 28, 2019

This open-label, Phase 2 study is studying whether the monoclonal antibody Avelumab, in combination with radiation therapy, is safe in the treatment of relaps... Read More


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .